modafinil

(redirected from Provigil)
Also found in: Medical.

mo·daf·i·nil

 (mə-dăf′ə-nĭl′)
n.
A nonamphetamine stimulant drug, C15H15NO2S, that promotes wakefulness and is used to treat narcolepsy and other sleep disorders.

[moda-, origin unknown + alteration of (sul)finyl, one of its constituents.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

modafinil

(məʊˈdæfɪnɪl)
n
a stimulant drug used to treat narcolepsy
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

modafinil

n modafinilo
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
A second drug with the same indication and telephone number, modafinil (Provigil), is in the Provigil Pregnancy Registry.
Drugs he prescribed included Ambien, used for sleep, and Provigil, used to help wake up.
I want to tell you what I've learned about the high cost of two medications: aripiprazole, the generic of Abilify, and modafinil, the generic of Provigil, but the lessons learned may apply to other psychotropics--and Smokey Robinson and the Miracles said it best in a line from their 1960 hit song, "You'd better shop around."
to delay the launch of a generic version of the latter's sleep disorder drug Provigil in a tactic known as "pay for delay."
[USPRwire, Wed Jan 18 2017] Summary: Shopmedpills has indeed given its consumers a pleasant shock after the recent launch of their new product, Provigil which falls in the Smart Drug or Nootropic Category.
Expiry of the blockbuster patented drugs such as Gleevec, Namenda, Provigil, Crestor, Benicar etc.
According to the Federal Trade Commission, the pharmaceutical company Cephalon, which makes Provigil, a drug used to treat sleep disorders, sued four generic drugmakers in 2005-06 for patent infringement and later paid them more than $300 million collectively to drop their challenges to Provigil's patents and to stop selling their generics for six years, until April 2012.
The agency alleged that Cephalon, which was later purchased by Teva in 2011, chose to buy off the competition after the patent for Provigil expired.
Consider Dexedrine and Provigil, two drugs that are FDA-approved to treat narcolepsy and other disorders.
Cognitive enhancement drugs (CEDs), such as Ritalin, Adderall, and Provigil, are most commonly known for their use in treating patients with Attention Deficit Hyperactivity Disorder (ADHD).